Treatment for COVID-19 Positive Patients

Facility/Clinic: Wilmington Health

Age: 18 and older

Gender: either

Description: Study to investigate orally administered PF-07321332/Ritonavir compared with placebo in non-hospitalized symptomatic adult participants with COVID-19

Enrollment: Open

Patient Commitment Duration: 10 visits

Patient Compensation: $100 per visit

The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial.
Please call 910-799-5500 between the hours of 8am-5pm for general research questions.